SCHEMBL27291358

SCHEMBL27291358

CCCCC(CC(=O)OC)CC(=O)OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 5/20 0.48
CA1 P00915 2/20 0.48
TSHR P16473 5/20 0.47
CYP3A4 P08684 3/20 0.47
ATM Q13315 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
RECQL P46063 2/20 0.42
BIRC2 Q13490 1/20 0.41
ALDH1A1 P00352 2/20 0.41
ZDHHC7 Q9NXF8 1/20 0.41
MEN1 O00255 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.39
POLB P06746 1/20 0.39
POLA1 P09884 1/20 0.39
CA12 O43570 1/20 0.39
CA14 Q9ULX7 1/20 0.39
MAPK1 P28482 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14022813 0.92 CYP3A4 (0.53) CA2CA1TSHRCYP3A4ATM
SCHEMBL23115434 0.90 ZDHHC7 (0.50) CA2CA1TSHRCYP3A4ATM
SCHEMBL15027359 0.89 ZDHHC7 (0.48) CA2CA1TSHRCYP3A4ATM
SCHEMBL19645435 0.88 ZDHHC7 (0.52) RECQLBIRC2ZDHHC7MEN1HPGD
SCHEMBL5076044 0.88 ZDHHC7 (0.52) RECQLBIRC2ZDHHC7MEN1HPGD
SCHEMBL5075427 0.88 ZDHHC7 (0.52) RECQLBIRC2ZDHHC7MEN1HPGD
SCHEMBL5074118 0.88 ZDHHC7 (0.52) RECQLBIRC2ZDHHC7MEN1HPGD
SCHEMBL5079165 0.88 ZDHHC7 (0.52) RECQLBIRC2ZDHHC7MEN1HPGD
SCHEMBL22590010 0.88 ZDHHC7 (0.52) RECQLBIRC2ZDHHC7MEN1HPGD
SCHEMBL13506382 0.86 TSHR (0.42) CA2CA1TSHRCYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240207429-A1 LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME WILMINGTON TRUST, NATIONAL ASSOCIATION 2024-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240207429-A1 LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME PAICS, DHFR, CD44 CA2 4145/4885CA1 1084/4885TSHR 2696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.